Germany
# |
Name |
Free Cash Flow Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
18.15% |
Jan. 14, 2025 | USD 116.36 | -0.45% |
|
Germany |
|
2 |
13.16% |
Jan. 14, 2025 | USD 20.20 | -1.60% |
|
Germany |
|
3 |
11.91% |
Feb. 28, 2024 | USD 12.40 | 1.02% |
NA
|
Germany |
|
4 |
10.91% |
Jan. 14, 2025 | USD 18.55 | -3.93% |
|
Germany |
|
5 |
7.66% |
Jan. 14, 2025 | USD 4.18 | 0.60% |
|
Germany |
|
6 |
4.07% |
Jan. 14, 2025 | USD 49.86 | 0.81% |
|
Germany |
|
7 |
3.08% |
Jan. 14, 2025 | USD 145.16 | 0.75% |
|
Germany |
|
8 |
2.28% |
Jan. 14, 2025 | USD 48.95 | 1.72% |
|
Germany |
|
9 |
0.62% |
Jan. 14, 2025 | USD 29.11 | 3.16% |
|
Germany |
|
10 |
-2.82% |
Jan. 14, 2025 | USD 42.87 | 0.60% |
|
Germany |
|
11 |
-3.16% |
Jan. 14, 2025 | USD 60.50 | -1.24% |
|
Germany |
|
12 |
-4.33% |
Jan. 14, 2025 | USD 21.54 | 1.09% |
|
Germany |
|
13 |
-8.87% |
Jan. 14, 2025 | USD 3.68 | 1.46% |
|
Germany |
|
14 |
-11.70% |
Jan. 14, 2025 | USD 4.96 | -2.24% |
|
Germany |
|
15 |
-13.80% |
Jan. 14, 2025 | USD 8.09 | -2.02% |
|
Germany |
|
16 |
-31.02% |
Jan. 14, 2025 | USD 2.61 | 0.60% |
|
Germany |
|
17 |
-37.87% |
Jan. 14, 2025 | USD 3.95 | -0.95% |
|
Germany |
|
18 |
-44.31% |
Jan. 14, 2025 | USD 2.11 | 3.12% |
|
Germany |
|
19 |
-60.31% |
Jan. 14, 2025 | USD 1.49 | -0.76% |
|
Germany |
|
20 |
-105.74% |
Jan. 14, 2025 | USD 1.09 | 3.54% |
|
Germany |
|
21 |
-202.84% |
Jan. 14, 2025 | USD 5.29 | 13.28% |
|
Germany |
The Biotechnology company in Germany with the highest Free Cash Flow Yield is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at 18.15%.
The Biotechnology company in Germany with the lowest Free Cash Flow Yield is Mainz Biomed B.V. (NasdaqCM: MYNZ) at -202.84%.
The top 10 Biotechnology companies in Germany by Free Cash Flow Yield are BioNTech SE, Bayer Aktiengesellschaft, CropEnergies AG, technotrans SE, VITA 34 AG, GEA Group Aktiengesellschaft, MERCK Kommanditgesellschaft auf Aktien, Eckert & Ziegler Strahlen- und Medizintechnik AG, Stratec SE and Biotest Aktiengesellschaft.
The bottom 10 Biotechnology companies in Germany by Free Cash Flow Yield are Mainz Biomed B.V., Medigene AG, NanoRepro AG, Vivoryon Therapeutics N.V., CureVac N.V., Heidelberg Pharma AG, Evotec SE, SynBiotic SE, BRAIN Biotech AG and Nynomic AG.